Asahi Kasei Kogyo Kabushiki Kaisha

Koito Manufacturing Company, Ltd.

Toyo Jozo Kabushiki Kaisha

Toray Industries, Inc.

Daisuke Mochizuki

Yukio Suzuki

Masao Yaso

Kensuke Shibata

Eiichi Hayashi

Hidetaka Anma

Hiroaki Hara

Masayuki Kobayashi

Yuji Kogami

Nobuyuki Takahashi

Helmut Schmidt

Hideyuki Umetsu

Yasuaki Tsutsumi

Masaaki Nakabayashi

Hideki Matsumoto

Ertugrul Arpac

Kei Saitoh

Tetsu Saito

Naoya Ouchiyama

Satoshi Shuto

Kazuhito Osada

Hisayoshi Daichou

Hideyuki Watanabe

Masaru Kaneko

Takehiko Sasahara

Hideaki Yamamoto

Yuki Takahashi

Carsten Schmidt

Takenao Yoshimura

Naomi Aono

Takeo Higashino

Savas Guven

Teruhisa Yamada

A method for producing a vehicle rear module that includes: a clear member monolithically including a lamp section and a window section; and a colored member for shielding at least part of a vehicle interior from the exterior. The method for producing the vehicle rear module comprises: a step for injecting a transparent resin from a single resin injection hole into a first cavity to form the clear member; and a step for injecting a colored resin from a plurality of resin injection holes into a second cavity to form the colored member.

Method of manufacturing vehicle rear module, vehicle back door, vehicle rear module, and vehicle module

A polyphenylene sulfide resin composition has excellent heat resistance, flowability and lightweight property as well as surface smoothness and impact resistance. The polyphenylene sulfide resin composition includes 1 to 30 parts by weight of a mica (b) having an aspect ratio of not less than 80, relative to 100 parts by weight of a polyphenylene sulfide resin (a).

Polyphenylene sulfide resin composition, production method thereof and reflector

Disclosed is a process of preparing a moulded article, comprising 1) hydrolyzing a) at least one silane having one non-hydrolysable organic group, and b) at least one compound selected from b1) a silane having two non-hydrolysable organic groups, and b2) a hydrolysable polysiloxane, or a mixture thereof, and c) optionally at least one silane having no non-hydrolysable organic group, to prepare a composite composition comprising a hydrolysate or condensate, 2) placing the composite composition in a mould, 3) curing the composite composition to increase the degree of condensation, 4) removing the moulded article from the mould, and 5) heat treating the moulded article at a temperature of at least 100&#xb0; C. The moulded article is preferably an optical lens which may be used for automobile headlights.

Siloxane composite-based light-weight optical lenses

A lamp reflector having a substrate prepared by injection molding a bulk molding compound (BMC). The BMC has a matrix resin mainly including: an unsaturated polyester resin and glass fiber as a reinforcing inorganic filler, and hollow glass spheres in an amount of 10 to 40% by volume based on the BMC as an additional inorganic filler.

Lamp reflector including bulk molding compound

A lamp body for a vehicle lighting unit includes a PC/PTT alloy material in which 80 to 50% by weight of a polycarbonate resin (hereinafter referred to as a PC) and 20 to 50% by weight of a polytrimethylene terephthalate resin (hereinafter referred to as a PTT) are contained as principal components and 5 to 10% by weight of a filler is added with respect to the total weight of the PC and the PTT. The lamp body constituted by the PC/PTT alloy material can be thermally welded to a lens formed of the PC, and has a heat resistance, a chemical resistance and a bending rigidity which are almost identical to those of a lamp body formed of a polypropylene. Therefore, the lens and the lamp body can be bonded and integrated by a thermal welding method.

Lamp body for vehicle lighting unit and lighting unit for vehicle

2,3-dihydrobenzofuran derivatives, method for producing the same, and

Disclosed are a 2,3-dihydrobenzofuran derivative represented by formula (1) or a salt thereof, a method for producing the same, and use thereof: ##STR1## wherein R.sup.1 represents a hydrogen atom or a lower alkyl group; n is an integer of from 2 to 6; A represents a carbonyl group or a sulfonyl group; R.sup.2 represents a hydrogen atom, a halogen atom, a lower alkyl group (which is unsubstituted or substituted with at least one halogen atom), a lower alkoxy group, a hydroxyl group, a nitro group or a cyano group; and * represents an asymmetric carbon atom. A 2,3-dihydrobenzofuran derivative of the present invention or a salt thereof has a strong affinity for a serotonin 1A receptor, and, therefore, is useful for prevention and treatment of serotonergic neuron-related diseases, such as anxiety, depression, high blood pressure, emeses (including emeses induced by motion sickness, space sickness and dizziness, etc.) and the like.

2,3-dihydrobenzofuran derivatives

An azepine compound of the formula ##STR1## wherein R is (a) ##STR2## in which R.sup.1 is hydrogen, lower alkyl, lower alkoxy, hydroxy, halogen, or optionally substituted phenyl, and n is 0 or 1, (b) cycloalkyl of C.sub.5-8 which is optionally substituted by lower alkyl, (c) norbornyl, (d) bicyclo[3.3.1]nonyl, (e) naphthyl, (f) 1,3-benzoxolyl, (g) pyridyl, or (h) thienyl, m is an integer of 0-4, and C* is an asymmetric carbon, and nontoxic salts thereof, processes for producing the same, and therapeutic agents containing the same as the active ingredient for treating diseases related to .sigma.-receptor. The compound (1) and nontoxic salts thereof have a high affinity for .sigma.-receptor but scarcely any affinity for other receptors, thus being utilized for treating diseases related to .sigma.-receptor, such as schizophrenia.

Azepine derivatives and use thereof

Adamantane derivative, process for producing the same, and use thereof

Aminoalkylcyclopropane derivatives

2-alkoxy-5,6,7,8-tetrahydroquinoxaline derivatives, and production

Described herein are pyrazolo[1,5-a]pyridine-3-carboxylic acid derivatives represented by the following formula (I): ##STR1## wherein R.sub.1 and R.sub.2 individually mean a hydrogen atom or a lower alkyl group, R.sub.3 denotes an azabicyclo group containing a tertiary nitrogen atom, and Y stands for --O-- or --NH--, or salts thereof. Their preparation process and serotonin receptor antagonists containing them as active ingredients are also described.

Pyrazolo[1,5-a]pyridine-3-carboxylic acid derivatives and their

A compound of the formula ##STR1## wherein Q is --CO-- or --CH.sub.2 --, R is hydroxyl, lower alkoxy, halogen, --NH-lower alkylene-OH, --NH-lower alkylene-arylthio, --NH-lower alkylene-halogen, ##STR2## is dilower alkylamino, cycloalkylamino, morpholino, ##STR3## in which R.sub.9 is hydrogen, lower alkyl or aryl, R.sub.10 is hydrogen, lower alkyl, hydroxy-lower alkyl, hydroxy-lower alkoxy-lower alkyl or di(aryl)-lower alkyl, m is an integer from 4 to 6, n is 2 or 3, R.sub.1 is alkyl or aryl-lower alkyl, R.sub.2 and R.sub.3 are each lower alkyl, or together form tetramethylene, and R.sub.4 is hydrogen, lower alkyl or aryl, in which aryl is phenyl which is optionally substituted with a group selected from the group consisting of 1-3 halogen, nitro, lower alkyl and lower alkoxy, or a pharmaceutically acceptable salt thereof, inhibits blood platelet aggregation, has vasodilating activity and inhibits lipoperoxide generation.

2-substituted alkoxy-3-substituted-pyrazines

A compound of the formula ##STR1## wherein Q is --CO-- or --CH.sub.2 --, R is hydroxyl, lower alkoxy, halogen, --NH-lower alkylene-OH, --NH-lower alkylene-arylthio, --NH-lower alkylene-halogen, ##STR2## in which ##STR3## is dilower alkylamino, cycloalkylamino, morpholino, ##STR4## in which R.sub.9 is hydrogen, lower alkyl or aryl, R.sub.10 is hydrogen, lower alkyl, hydroxy-lower alkyl, hydroxy-lower alkoxy-lower alkyl or di(aryl)-lower alkyl, m is an integer from 4 to 6, n is 2 or 3, R.sub.1 is alkyl or aryl-lower alkyl, R.sub.2 and R.sub.3 are each lower alkyl, or together form tetramethylene, and R.sub.4 is hydrogen, lower alkyl or aryl, in which aryl is phenyl which is optionally substituted with a group selected from the group consisting of 1-3 halogen, nitro, lower alkyl and lower alkoxy, or a pharmaceutically acceptable salt thereof, inhibits blood platelet aggregation, has vasodilating activity and inhibits lipoperoxide generation.

Growing community of inventors

Shizuoka, Japan

Daisuke Mochizuki